ArticleThe Annals of thoracic surgery2026
Durability and Outcomes of Mitral Reintervention After Surgical Mitral Repair in Patients 65 Years and Older in the United States.
Article in The Annals of thoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanisms of Mitral Valve Repair Failure in a Redo Cohort: Association with Patient Characteristics and Initial Repair Features.Diseases (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundNational data on the durability of surgical mitral repair and outcomes of reintervention are lacking. This study aimed to quantify the national incidence and outcomes of mitral reintervention after surgical repair.
methodsThe US Centers for Medicare & Medicaid Services claims identified patients aged ≥65 years who underwent surgical mitral repair followed by reintervention (replacement, repeat repair, or transcatheter edge-to-edge repair [TEER]) between 2012 and 2023. The 30-day and 3-year mortality, stroke, and heart failure readmission after reintervention were assessed using logistic regression and adjusted Cox proportional hazards modeling. Competing risks were used to estimate the probability of reintervention, heart failure, and stroke.
resultsOf 45,482 patients undergoing surgical mitral repair, 1560 required reintervention. Of these, 1223 (78.4%) had surgical replacement, 164 (10.5%) underwent surgical repair, and 173 (11.1%) had TEER. The median time to reintervention was 1.9 years (interquartile range, 0.64-4.1 years). The cumulative incidence of reintervention at 9 years was 5%. The adjusted 30-day rate of heart failure readmission was lowest among patients who underwent TEER (4.8% vs 15.9% replacement, vs 14.6% repeat repair; P < .01), whereas 30-day mortality and stroke readmission rates did not differ among the reintervention approaches. At 3 years, there was no significant difference in survival, heart failure readmissions, or stroke readmissions by reintervention approach.
conclusionsSurgical mitral repair is durable, with a low 9-year risk of reintervention. The reintervention approach does not affect mortality, heart failure, and stroke readmissions at 3 years, a finding suggesting that any of these approaches is appropriate for reintervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.